- Home
- FRSH vs CLDX Comparison
FRSH vs CLDX Comparison
Compare FRSH & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRSH | CLDX |
|---|---|---|
| Founded | 2010 | N/A |
| Country | United States | United States |
| Employees | N/A | 198 |
| Industry | EDP Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.0B |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | FRSH | CLDX |
|---|---|---|
| Price | $11.87 | $38.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 10 |
| Target Price | $14.86 | ★ $46.60 |
| AVG Volume (30 Days) | ★ 5.0M | 684.9K |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 296.88 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $838,809,000.00 | $12,743,000.00 |
| Revenue This Year | $16.30 | $111.39 |
| Revenue Next Year | $14.09 | $235.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 16.43 | ★ 87.78 |
| 52 Week Low | $6.79 | $22.10 |
| 52 Week High | $13.99 | $45.14 |
Technical Indicators
Market Signals| Indicator | FRSH | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 42.48 | 42.99 |
| Support Level | $11.62 | $28.51 |
| Resistance Level | $12.28 | $40.30 |
| Average True Range (ATR) | 0.41 | 1.26 |
| MACD | -0.26 | -0.37 |
| Stochastic Oscillator | 6.61 | 18.54 |
Price Performance
Historical ComparisonAbout FRSH Freshworks Inc.
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions. It derives maximum revenue from North America.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.